Patent · US Active

Dosage forms of controlled release at specific gastrointestinal sites

US12102721B2 · kind B2 · utility

1Cited by

52References

11Claims

0Family size

Assignee

Triastek, Inc. · CN

Inventors

Senping CHENG · Nanjing, CN
Xiaoling Li · Dublin, US
Feihuang DENG · Nanjing, CN
Juan Yao · Yichang City, CN

Key dates

Filing date	Jan 25, 2018
Grant date	Oct 1, 2024
Priority date	—
Expiry date	Jan 25, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A dosage form of controlled release at specific gastrointestinal sites is provided. The dosage form includes a shell defining a first and a second compartment, a first active pharmaceutical ingredient (API) loaded in the first compartment, and a second API loaded in the second compartment, wherein the first API and the second API can be the same or different. The shell includes a first material soluble in a first gastrointestinal site and a second material soluble in a second gastrointestinal site.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.